The future of biosimilar drugs in the U.S.

September 24, 2011 @ 1:00 am

Share:

National Press Foundation Webinar, Thursday, Sept. 24, noon ET

Jeremy A. Greene, M.D., Ph.D., associate professor of medicine and the history of medicine and Elizabeth Treide and A. McGehee Harvey Chair in the History of Medicine at Johns Hopkins University; and Michael Kleinrock, research director for the IMS Institute for Healthcare Informatics, will discuss the effect biotech drugs have on health care in a webinar sponsored by the National Press Foundation. Biosimilars are a type of biological product (meaning they are made from living organisms) that the FDA has licensed because they are similar to another FDA-approved biological product.

Register online here. Contact Amun Nadeem for more information.

Note that pharmaceutical company Sanofi US Services Inc. provided funding for this webinar.

Details

  • Date: September 24, 2011
  • Time:
    1:00 am EDT
  • Event Category:
  • Event Tags: